Get started
Work

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial

Year: 2023
Type: erratum
DOI: 10.1038/s41591-023-02500-7
Authors: Jeroen van Dorp, Christodoulos Pipinikas, Britt B. M. Suelmann, Niven Mehra, Nick van Dijk, Giovanni Marsico, Maurits L. van Montfoort, Sophie Hackinger, Linde M. Braaf, Tauanne Amarante, Charlaine van Steenis, Kirsten McLay, Antonios Daletzakis, Daan van den Broek, Maaike W. van de Kamp, Kees Hendricksen, Jeantine M. de Feijter, Thierry N. Boellaard, Richard P. Meijer, Antoine G. van der Heijden, Nitzan Rosenfeld, Bas W. G. van Rhijn, Greg Jones, Michiel S. van der Heijden
Institutions: The Netherlands Cancer Institute, University Medical Center Utrecht, Radboud University Medical Center, Cancer Research UK, Cancer Research UK Cambridge Center, Caritas-Krankenhaus St. Josef, University of Regensburg
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4384522798
Cites:
Cited by: 8
Related to: 10